注射用静菌水市場：容器タイプ別、用途別、エンドユーザー別、地域別

注射用静菌水の世界市場規模は、2024年に12億2,000万米ドルと推定され、2024年から2031年までのCAGRは8％を示し、2031年には20億9,000万米ドルに達すると予測されます。

図.注射用静菌水市場シェア（%）、地域別、2024年

注射用静菌水とは、調製時や使用時に接種された微生物の増殖を抑制するために、適切な濃度の防腐剤を含む無菌水を指します。静菌水は、注射や点滴中の微生物汚染のリスクを排除するために、粉末薬剤やその他の製剤の再構成に使用されます。病院や診療所では、抗生物質、抗真菌薬、その他の注射薬などの薬剤の再構成に使用されます。慢性疾患や感染症の世界の流行とヘルスケア支出の増加は、予測期間中に注射用静菌水の需要を押し上げる可能性があります。

市場力学：

がんや心血管障害などの慢性疾患の有病率の増加は、様々な治療用注射薬の需要を押し上げる可能性があり、これが予測期間中の注射用静菌水の世界市場の成長を促進すると予想されます。特に新興国では、医療施設へのアクセス改善とともにヘルスケア支出が増加しており、市場成長の原動力となる可能性があります。しかし、通常の生理食塩水のような代替品が入手可能であることが、市場成長の妨げになる可能性があります。一方、より効果的な防腐剤や、より幅広い注射薬に適合する製剤の開発に向けた研究が進んでおり、近い将来、メーカーに有利な機会をもたらす可能性があります。

本調査の主な特徴

本レポートでは、世界の注射用静菌水市場を詳細に分析し、2023年を基準年とした予測期間（2024-2031年）の市場規模（10億米ドル）と年間平均成長率（CAGR%）を掲載しています。

さまざまなセグメントにわたる潜在的な収益機会を解明し、この市場の魅力的な投資提案のマトリックスについて説明しています。

また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する主要考察も提供しています。

本調査の対象となる主要企業には、B. Braun Medical Inc、HOSPIRA、Medline、Baxter、ICU Medical、Hyperdrugなどがあります。

本レポートの洞察により、マーケティング担当者や各企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関して、十分な情報に基づいた意思決定を行うことができます。

注射用静菌水の世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。

利害関係者は、世界の注射用静菌水市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• 影響分析
• 市場動向
• 主な発展
• 規制シナリオ
• 買収と提携のシナリオ
• 資金調達と投資
• PEST分析
• ポーターの分析

第4章 世界の注射用静菌水市場- コロナウイルス（COVID-19）パンデミックの影響

• 全体的な影響
• 政府の取り組み
• COVID-19による市場への影響

第5章 世界の注射用静菌水市場、容器タイプ別、2019年-2031年

• シングルドーズバイアル
• マルチドーズバイアル

第6章 世界の注射用静菌水市場、用途別、2019年-2031年

• 医薬品製造
• 医療用途
• 診断用途
• その他

第7章 世界の注射用静菌水市場、エンドユーザー別、2019年-2031年

• 病院・クリニック
• 診断ラボ
• 研究ラボ
• その他

第8章 世界の注射用静菌水市場、地域別、2019年-2031年

• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第9章 競合情勢

• 企業プロファイル
  • Baxter International Inc.
  • Fresenius Kabi AG
  • Hospira, Inc.
  • B. Braun Melsungen AG
  • Eagle Pharmaceuticals, Inc.
  • Sagent Pharmaceuticals, Inc.
  • Baxter Healthcare Corporation
  • MediPharma
  • AstraZeneca
  • Hikma Pharmaceuticals PLC
  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz（a Novartis division）
  • Merck &Co., Inc.
  • GlaxoSmithKline PLC
  • Cipla Limited
  • Sun Pharmaceutical Industries Ltd.
  • Roche Holding AG
  • Alvogen
  • Zydus Cadila

第10章 アナリストの推奨事項

第11章 参考文献と調査手法

• 参考文献
• 調査手法

Global bacteriostatic water for injection market is estimated to be valued at USD 1.22 Billion in 2024 and is expected to reach USD 2.09 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 8% from 2024 to 2031.

Figure. Bacteriostatic Water for Injection Market Share (%), By Region, 2024

Bacteriostatic water for injection refers to sterile water that contains a suitable concentration of preservative to inhibit the growth of micro-organisms inoculated during its preparation or intended use. Bacteriostatic water is used in the reconstitution of powdered medications and other preparations to eliminate the risk of microbial contamination during injection or infusion. It is used in hospitals and clinics for reconstituting medications such as antibiotics, antifungal drugs and other injectable drugs. Growing prevalence of chronic and infectious diseases worldwide along with rising healthcare expenditures can boost demand for bacteriostatic water for injection over the forecast period.

Market Dynamics:

Increasing prevalence of chronic diseases such as cancer and cardiovascular disorders can boost demand for various therapeutic injectable drugs, and this is expected to drive the global bacteriostatic water for injection market growth during the forecast period. Rising healthcare expenditures along with improving access to healthcare facilities especially in developing countries can drive the market growth. However, availability of substitute products such as normal saline can hamper the market growth. Meanwhile, ongoing research towards development of more effective preservatives and formulations compatible with wider range of injectable drugs can offer lucrative opportunities for manufacturers in the near future.

Key features of the study:

This report provides in-depth analysis of the global bacteriostatic water for injection market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

Key companies covered as a part of this study include B. Braun Medical Inc, HOSPIRA, Medline, Baxter, ICU Medical and Hyperdrug

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global bacteriostatic water for injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bacteriostatic water for injection market

Detailed Segmentation-

• Container Type Insights (Revenue, USD Bn, 2019 - 2031)
  • Single-Dose Vials
  • Multi-Dose Vials
• Application Insights (Revenue, USD Bn, 2019 - 2031)
  • Pharmaceutical Manufacturing
  • Medical Use
  • Diagnostic Applications
  • Others
• End User Insights (Revenue, USD Bn, 2019 - 2031)
  • Hospital & Clinics
  • Diagnostic Labs
  • Research Labs
  • Others
• Regional Insights (Revenue, USD Bn 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Baxter International Inc.
  • Fresenius Kabi AG
  • Hospira, Inc.
  • Braun Melsungen AG
  • Eagle Pharmaceuticals, Inc.
  • Sagent Pharmaceuticals, Inc.
  • Baxter Healthcare Corporation
  • MediPharma
  • AstraZeneca
  • Hikma Pharmaceuticals PLC
  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz (a Novartis division)
  • Merck & Co., Inc.
  • GlaxoSmithKline PLC
  • Cipla Limited
  • Sun Pharmaceutical Industries Ltd.
  • Roche Holding AG
  • Alvogen
  • Zydus Cadila

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Container Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Bacteriostatic Water for Injection Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Bacteriostatic Water for Injection Market, By Container Type, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Single-Dose Vials
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Multi-Dose Vials
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Bacteriostatic Water for Injection Market, By Application, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Pharmaceutical Manufacturing
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Medical Use
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Diagnostic Applications
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Bacteriostatic Water for Injection Market, By End User, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospital & Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Diagnostic Labs
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Research Labs
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Bacteriostatic Water for Injection Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2031
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Baxter International Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Fresenius Kabi AG
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Hospira, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • B. Braun Melsungen AG
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eagle Pharmaceuticals, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sagent Pharmaceuticals, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Baxter Healthcare Corporation
  • MediPharma
  • AstraZeneca
  • Hikma Pharmaceuticals PLC
  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz (a Novartis division)
  • Merck & Co., Inc.
  • GlaxoSmithKline PLC
  • Cipla Limited
  • Sun Pharmaceutical Industries Ltd.
  • Roche Holding AG
  • Alvogen
  • Zydus Cadila

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact